Floating Button
Home News Covid-19

Pfizer, BioNTech vaccine gets full approval from US regulators

Bloomberg
Bloomberg • 3 min read
Pfizer, BioNTech vaccine gets full approval from US regulators
The Covid-19 vaccine will be marketed under the name Comirnaty.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

The Covid-19 vaccine made by Pfizer Inc and BioNTech SE was granted a full approval by US regulators, a move that is expected to help bolster the immunization drive amid a surge in infections caused by the delta variant.

The Food and Drug Administration said in a statement on Monday that it had cleared the vaccine for the prevention of Covid-19 in individuals 16 years of age and older. It will be marketed under the Comirnaty.

The vaccine continues to be available to people age 12 to 15 under an emergency-use authorization, the agency said.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.